ATE298576T1 - Arzneizubereitungen - Google Patents

Arzneizubereitungen

Info

Publication number
ATE298576T1
ATE298576T1 AT99967310T AT99967310T ATE298576T1 AT E298576 T1 ATE298576 T1 AT E298576T1 AT 99967310 T AT99967310 T AT 99967310T AT 99967310 T AT99967310 T AT 99967310T AT E298576 T1 ATE298576 T1 AT E298576T1
Authority
AT
Austria
Prior art keywords
medicinal preparations
medicinal
preparations
Prior art date
Application number
AT99967310T
Other languages
English (en)
Inventor
Terrence C Dahl
Lung-Chi J Yuan
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/211,613 external-priority patent/US6635278B1/en
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Application granted granted Critical
Publication of ATE298576T1 publication Critical patent/ATE298576T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99967310T 1998-12-15 1999-12-14 Arzneizubereitungen ATE298576T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11240398P 1998-12-15 1998-12-15
US09/211,613 US6635278B1 (en) 1998-12-15 1998-12-15 Pharmaceutical formulations
PCT/US1999/029626 WO2000035460A2 (en) 1998-12-15 1999-12-14 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ATE298576T1 true ATE298576T1 (de) 2005-07-15

Family

ID=26809911

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99967310T ATE298576T1 (de) 1998-12-15 1999-12-14 Arzneizubereitungen

Country Status (18)

Country Link
EP (1) EP1140114B1 (de)
JP (1) JP4750946B2 (de)
KR (1) KR100624214B1 (de)
CN (2) CN1202829C (de)
AR (1) AR021670A1 (de)
AT (1) ATE298576T1 (de)
AU (1) AU759869B2 (de)
BR (1) BRPI9916820B8 (de)
CA (1) CA2355239C (de)
CO (1) CO5261557A1 (de)
DE (1) DE69926012T2 (de)
ES (1) ES2245130T3 (de)
ID (1) ID30032A (de)
MY (1) MY126526A (de)
NZ (1) NZ511855A (de)
TR (1) TR200101746T2 (de)
TW (1) TWI230618B (de)
WO (1) WO2000035460A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20030047B1 (hr) 2000-07-21 2016-02-26 Gilead Sciences, Inc. Prolijekovi koji su fosfonatni analozi nukleotida i metode njihovog odabira te njihova priprava
ATE352546T1 (de) * 2001-07-31 2007-02-15 Lundbeck & Co As H Kristalline zusammensetzung enthaltend escitalopram
WO2004043972A1 (fr) * 2002-11-12 2004-05-27 Tianjin Kinsly Pharmaceutical Co., Ltd. Nouvelle forme cristalline d'adefovir dipivoxil et sa composition
EP1635847B1 (de) 2003-06-13 2019-07-31 IDH Holding ApS Behandlung von symptomen im zusammenhang mit bakterieller vaginose
ITMI20071594A1 (it) * 2007-08-02 2009-02-03 Solmag Spa Forma cristallina monoidrata di adefovir dipivoxil
KR20100031045A (ko) * 2008-09-11 2010-03-19 씨제이제일제당 (주) 아데포비어 디피복실의 정제방법
CN102149715A (zh) * 2008-09-17 2011-08-10 Cj第一制糖株式会社 肝适能的稳定化固态分散物及其制备方法
KR101089620B1 (ko) * 2009-07-20 2011-12-06 경희대학교 산학협력단 무수결정형 아데포비어 디피복실 및 이온성 액체를 사용한 이의 제조 방법
CA2771403C (en) 2009-08-19 2015-02-24 Eisai R&D Management Co. Ltd. Quinoline derivative-containing pharmaceutical composition
EP2343056A1 (de) 2009-12-30 2011-07-13 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Herstellung einer stabilen festen Dispersion von amorphem Adefovir dipivoxil
KR20240064733A (ko) 2015-03-04 2024-05-13 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
US10610527B2 (en) * 2015-12-22 2020-04-07 X4 Pharmaceuticals, Inc. Methods for treating immunodeficiency disease
EP4696303A1 (de) * 2024-08-14 2026-02-18 Bonutra AG Vollnaturgranulat

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58201726A (ja) * 1982-05-18 1983-11-24 Meiji Seika Kaisha Ltd 安定な製剤の製造法
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
US4704365A (en) * 1986-02-24 1987-11-03 Abbott Laboratories Composition and method for stabilization of dinucleotides
CA2035841C (en) * 1990-02-22 1996-02-13 Harry B. Demopoulos Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture
DK0481214T3 (da) * 1990-09-14 1999-02-22 Acad Of Science Czech Republic Prolægemidler af phosphonater
JPH0825905B2 (ja) * 1990-11-20 1996-03-13 武田薬品工業株式会社 医薬固形組成物用安定化剤および安定化方法
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
ES2133158T3 (es) * 1993-01-19 1999-09-01 Warner Lambert Co Formulacion ci-981 oral, estable y proceso de preparacion del mismo.
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
JP2974550B2 (ja) * 1993-06-01 1999-11-10 ビオフェルミン製薬株式会社 経口投与用固体組成物
US5919776A (en) * 1996-12-20 1999-07-06 Merck & Co., Inc. Substituted aminoquinolines as modulators of chemokine receptor activity
JP2762998B2 (ja) * 1997-04-25 1998-06-11 武田薬品工業株式会社 医薬固形組成物用安定化剤および安定化方法
JPH114666A (ja) * 1997-06-17 1999-01-12 Otsuka Pharmaceut Co Ltd マグネシウム補給発泡剤組成物
ES2187991T3 (es) * 1997-07-25 2003-06-16 Gilead Sciences Inc Composiciones de analogo de nucleotido.

Also Published As

Publication number Publication date
CA2355239C (en) 2008-03-18
JP2002532429A (ja) 2002-10-02
BRPI9916820B1 (pt) 2018-04-03
BRPI9916820B8 (pt) 2023-04-25
DE69926012T2 (de) 2006-05-04
TR200101746T2 (tr) 2001-12-21
ID30032A (id) 2001-11-01
HK1040488A1 (en) 2002-06-14
EP1140114B1 (de) 2005-06-29
AU2361300A (en) 2000-07-03
AR021670A1 (es) 2002-07-31
ES2245130T3 (es) 2005-12-16
CN1682743A (zh) 2005-10-19
BRPI9916820A2 (pt) 2001-10-30
CA2355239A1 (en) 2000-06-22
EP1140114A2 (de) 2001-10-10
CN100361664C (zh) 2008-01-16
MY126526A (en) 2006-10-31
NZ511855A (en) 2003-07-25
CN1202829C (zh) 2005-05-25
JP4750946B2 (ja) 2011-08-17
DE69926012D1 (de) 2005-08-04
KR100624214B1 (ko) 2006-09-18
AU759869B2 (en) 2003-05-01
KR20010080765A (ko) 2001-08-22
WO2000035460A2 (en) 2000-06-22
CO5261557A1 (es) 2003-03-31
TWI230618B (en) 2005-04-11
CN1330547A (zh) 2002-01-09
WO2000035460A3 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
NO992339L (no) Farmasöytiske formuleringer
IS6040A (is) Valdekoxib efnablöndur
IS5425A (is) Læknislyf
NO20005913L (no) Legemiddelsammensetning
NO20012915L (no) Ny farmasöytisk formulering
NO20071303L (no) Farmasoytiske preparater
NO20020304L (no) Konserverte farmasoytiske preparater
ATE266383T1 (de) Dermatologische zubereitungen
NO980546D0 (no) Farmasöytiske midler
DK1466615T3 (da) Farmaceutisk præparat
ATE332132T1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
DE59707298D1 (de) Desodorierende zubereitungen
DE69926012D1 (de) Arzneizubereitungen
ID16781A (id) Formulasi-formulasi farmasi
ITMI941169A0 (it) Formulazioni farmaceutiche
NO994619L (no) Farmasöytiske blandinger
ATE246494T1 (de) Brausezubereitungen
NO20003141D0 (no) Farmasøytiske blandinger
ATE237309T1 (de) Arzneizubereitungen
EP1142589A4 (de) Medizinische zusammensetzungen
FI951155A7 (fi) Farmaseuttinen valmiste
DE50009295D1 (de) Vernetzerfreie zubereitungen
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties